Inflammatory diseases in older adults: Polymyalgia rheumatica

Geriatrics

Volumn 59, Issue 11, 2004, Pages 39-44

  Spiera, Robert ^a   Spiera, Harry ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Glucocorticoids; Osteoporosis; Rheumatoid arthritis

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; METHYLPREDNISOLONE; PLACEBO; PREDNISONE; STEROID; VITAMIN D;

ADULT; AGED; DEGENERATIVE DISEASE; DOSE RESPONSE; DRUG EFFECT; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATORY DISEASE; METABOLIC DISORDER; MUSCLE WEAKNESS; OSTEOPOROSIS; REVIEW; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN BRUISING;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; PREDNISONE; PROGNOSIS; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 8844280818     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41(5):778-99.
2. Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis 1989; 48(8):662-6.